M05.119

Clinical Causes: Autoimmune response characteristic of rheumatoid arthritis leading to inflammation in lung tissue Genetic predisposition contributing to immune system dysregulation Environmental factors such as smoking or exposure to certain toxins that may increase risk Long-standing rheumatoid arthritis increasing the likelihood of extra-articular involvement Presence of specific autoantibodies that may target lung tissue

Key Symptoms: Shortness of breath, especially during physical activity Persistent coughing, which may be dry or produce mucus Chest discomfort or pain Fatigue and general feeling of being unwell Joint pain and swelling, particularly in the shoulders but may involve other joints Reduced exercise tolerance

Diagnosis Path: Medical history and physical examination focusing on joint and lung symptoms Chest imaging studies such as X-rays or high-resolution CT scans to assess lung tissue Pulmonary function tests to evaluate lung capacity and airflow Blood tests for rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies Analysis of lung tissue through biopsy if necessary, to confirm inflammation or fibrosis Assessment of joint involvement and symptoms related to the shoulder

Treatment Protocols: Medications to control inflammation and suppress the immune response, such as disease-modifying antirheumatic drugs (DMARDs), including methotrexate and biologic agents Corticosteroids to reduce lung inflammation during flare-ups Physical therapy and pulmonary rehabilitation to improve lung function and joint mobility Management of symptoms through supplemental oxygen or other supportive therapies if indicated Monitoring lung function regularly to assess disease progression or response to therapy Addressing joint symptoms with medications or physical therapy to improve shoulder function Lifestyle modifications, including smoking cessation and avoidance of lung irritants